Candel Therapeutics, Inc.CADLNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+13.6%
5Y CAGR+28.4%
Year-over-Year Change
Research and development spending
3Y CAGR
+13.6%/yr
Annual compound
5Y CAGR
+28.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $30.50M | +57.9% |
| 2024 | $19.31M | -21.2% |
| 2023 | $24.51M | +17.9% |
| 2022 | $20.79M | +37.0% |
| 2021 | $15.18M | +73.4% |
| 2020 | $8.75M | +32.5% |
| 2019 | $6.61M | - |